Tarbox Family Office’s Takeda Pharmaceutical TAK Stock Holding History

Tarbox Family Office’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-805	Closed	-$12K	–	876
2022 Q1	$12K	Hold	805	–	–	﹤0.01%	364
2021 Q4	$11K	Hold	805	–	–	﹤0.01%	449
2021 Q3	$13K	Hold	805	–	–	﹤0.01%	453
2021 Q2	$14K	Hold	805	–	–	﹤0.01%	438
2021 Q1	$15K	Hold	805	–	–	﹤0.01%	369
2020 Q4	$15K	Hold	805	–	–	﹤0.01%	350
2020 Q3	$14K	Hold	805	–	–	﹤0.01%	339
2020 Q2	$14K	Hold	805	–	–	﹤0.01%	334
2020 Q1	$12K	Hold	805	–	–	﹤0.01%	308
2019 Q4	$16K	Hold	805	–	–	﹤0.01%	306
2019 Q3	$14K	Hold	805	–	–	﹤0.01%	292
2019 Q2	$14K	Hold	805	–	–	﹤0.01%	289
2019 Q1	$16K	Buy	+805	New	+$16.2K	0.01%	253

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tarbox Family Office's TAK Position: Q2 2022 in Review

Tarbox Family Office sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 805 shares — an estimated $12K sold.

Tarbox Family Office first reported a position in TAK in Q1 2019 and held it in 13 quarters. The position peaked at $16K in Q4 2019. 282 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Tarbox Family Office reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 805 Takeda Pharmaceutical shares in Q2 2022, an estimated $12K.
Tarbox Family Office first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 13 quarters.
Tarbox Family Office's Takeda Pharmaceutical position peaked at $16K in Q4 2019.
282 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.